The National Institutes of Health (NIH) is offering a cooperative agreement opportunity for the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) Clinical Trial Data Processing, Analysis, and Coordination Center. This initiative aims to renew support for core program activities, including the management, direction, and coordination of data processing and analysis to bolster the AMP SCZ Clinical Trial Network. The program is crucial for advancing research on pharmacological interventions for psychosis and requires collaboration among experts in clinical research and bioinformatics. The estimated total funding for this opportunity is $12 million, with one award anticipated. Interested applicants can reach out to Dr. Suzanne Garcia at suzanne.garcia@nih.gov or call 202-345-1260 for further information. Key dates include an estimated synopsis post date of September 24, 2025, and a close date of October 24, 2025, with project activities expected to commence on July 1, 2026.